$2.58 Billion is the total value of PFM Health Sciences, LP's 83 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 42.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | LILLY ELI & CO | $140,057,594 | +36.6% | 298,643 | 0.0% | 5.44% | +20.0% | |
| PEN | PENUMBRA INC | $123,871,922 | +23.5% | 360,030 | 0.0% | 4.81% | +8.5% | |
| HZNP | HORIZON THERAPEUTICS PUB L | $112,295,744 | -5.8% | 1,091,840 | 0.0% | 4.36% | -17.2% | |
| CYTK | CYTOKINETICS INC | $78,273,158 | -7.3% | 2,399,545 | 0.0% | 3.04% | -18.5% | |
| CNC | CENTENE CORP DEL | $75,036,776 | +6.7% | 1,112,480 | 0.0% | 2.91% | -6.2% | |
| HUM | HUMANA INC | $74,253,091 | -7.9% | 166,066 | 0.0% | 2.88% | -19.0% | |
| MRK | Buy | MERCK & CO INC | $68,802,557 | +40.2% | 596,261 | +29.3% | 2.67% | +23.3% |
| ABBV | Buy | ABBVIE INC | $67,971,016 | +47.6% | 504,498 | +74.6% | 2.64% | +29.7% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $66,275,126 | +23.5% | 702,588 | +8.3% | 2.57% | +8.6% |
| RSP | New | INVESCO EXCHANGE TRADED FD Tput | $61,367,364 | – | 410,100 | +100.0% | 2.38% | – |
| CAH | CARDINAL HEALTH INC | $60,504,278 | +25.3% | 639,783 | 0.0% | 2.35% | +10.1% | |
| ISRG | Sell | INTUITIVE SURGICAL INC | $58,828,383 | +28.7% | 172,043 | -3.8% | 2.28% | +13.2% |
| BIIB | New | BIOGEN INC | $56,495,440 | – | 198,334 | +100.0% | 2.19% | – |
| UNH | UNITEDHEALTH GROUP INC | $55,786,443 | +1.7% | 116,067 | 0.0% | 2.17% | -10.6% | |
| ICLR | Buy | ICON PLC | $53,432,462 | +288.4% | 213,559 | +231.5% | 2.08% | +241.3% |
| PRTA | PROTHENA CORP PLC | $52,886,001 | +40.9% | 774,546 | 0.0% | 2.05% | +23.8% | |
| IRTC | IRHYTHM TECHNOLOGIES INC | $50,644,022 | -15.9% | 485,468 | 0.0% | 1.97% | -26.1% | |
| SGEN | Buy | SEAGEN INC | $49,327,306 | +10.3% | 256,299 | +16.0% | 1.92% | -3.0% |
| HCA | Buy | HCA HEALTHCARE INC | $48,184,127 | +23.1% | 158,772 | +6.9% | 1.87% | +8.2% |
| DXCM | Sell | DEXCOM INC | $48,124,168 | -2.3% | 374,478 | -11.6% | 1.87% | -14.1% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $46,876,616 | +105.9% | 679,076 | +43.8% | 1.82% | +80.9% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $45,469,106 | +10.6% | 2,172,437 | +11.6% | 1.76% | -2.8% |
| MCK | MCKESSON CORP | $45,214,098 | +20.0% | 105,811 | 0.0% | 1.76% | +5.5% | |
| IQV | IQVIA HLDGS INC | $45,187,086 | +13.0% | 201,037 | 0.0% | 1.75% | -0.7% | |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $44,689,457 | +50.5% | 283,257 | +21.2% | 1.74% | +32.2% |
| MOH | MOLINA HEALTHCARE INC | $43,311,986 | +12.6% | 143,779 | 0.0% | 1.68% | -1.0% | |
| DHR | DANAHER CORPORATION | $42,165,600 | -4.8% | 175,690 | 0.0% | 1.64% | -16.3% | |
| THC | Buy | TENET HEALTHCARE CORP | $41,617,244 | +96.2% | 511,394 | +43.3% | 1.62% | +72.5% |
| SYK | New | STRYKER CORPORATION | $41,193,862 | – | 135,022 | +100.0% | 1.60% | – |
| ARGX | ARGENX SEsponsored adr | $40,817,202 | +4.6% | 104,732 | 0.0% | 1.58% | -8.0% | |
| BDX | Buy | BECTON DICKINSON & CO | $40,645,660 | +8.7% | 153,955 | +1.9% | 1.58% | -4.4% |
| ALKS | New | ALKERMES PLC | $36,038,319 | – | 1,151,384 | +100.0% | 1.40% | – |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $35,612,523 | -4.7% | 495,582 | -18.2% | 1.38% | -16.2% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $34,947,528 | -6.4% | 2,704,917 | -28.9% | 1.36% | -17.7% |
| ANTM | Buy | ELEVANCE HEALTH INC | $33,375,953 | +122.8% | 75,122 | +130.6% | 1.30% | +95.8% |
| TMO | THERMO FISHER SCIENTIFIC INC | $32,423,110 | -9.5% | 62,143 | 0.0% | 1.26% | -20.4% | |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $30,363,831 | +95.7% | 350,298 | +119.5% | 1.18% | +72.1% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $30,366,891 | +35.2% | 381,302 | +22.6% | 1.18% | +18.9% |
| KRTX | KARUNA THERAPEUTICS INC | $29,970,622 | +19.4% | 138,209 | 0.0% | 1.16% | +5.0% | |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $28,536,687 | +0.3% | 1,405,056 | -9.9% | 1.11% | -11.9% |
| WAT | WATERS CORP | $25,221,081 | -13.9% | 94,624 | 0.0% | 0.98% | -24.3% | |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $25,006,768 | +33.4% | 274,498 | -3.4% | 0.97% | +17.3% |
| BLUE | Buy | BLUEBIRD BIO INC | $23,968,048 | +64.4% | 7,285,121 | +58.9% | 0.93% | +44.6% |
| Buy | CARIBOU BIOSCIENCES INC | $23,676,193 | -11.0% | 5,570,869 | +11.1% | 0.92% | -21.8% | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $18,983,408 | – | 165,765 | +100.0% | 0.74% | – |
| NEVRO CORPnote 2.750% 4/0 | $16,192,610 | -1.6% | 17,500,000 | 0.0% | 0.63% | -13.5% | ||
| RETA | New | REATA PHARMACEUTICALS INCcl a | $14,799,188 | – | 145,147 | +100.0% | 0.58% | – |
| BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $14,771,520 | -4.3% | 15,000,000 | 0.0% | 0.57% | -15.7% | ||
| BSX | New | BOSTON SCIENTIFIC CORP | $14,517,594 | – | 268,397 | +100.0% | 0.56% | – |
| AXSM | New | AXSOME THERAPEUTICS INCcall | $14,372,000 | – | 200,000 | +100.0% | 0.56% | – |
| GBIO | Sell | GENERATION BIO CO | $14,285,898 | +25.5% | 2,597,436 | -1.9% | 0.56% | +10.3% |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $13,696,852 | – | 1,147,140 | +100.0% | 0.53% | – |
| ERASCA INC | $13,240,990 | -8.3% | 4,797,460 | 0.0% | 0.51% | -19.4% | ||
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $11,773,388 | -49.5% | 1,299,491 | -59.5% | 0.46% | -55.6% |
| ABCM | New | ABCAM PLCads | $11,658,242 | – | 476,430 | +100.0% | 0.45% | – |
| EPIX | Buy | ESSA PHARMA INC | $11,353,373 | -8.1% | 4,204,953 | +1.0% | 0.44% | -19.2% |
| FXI | New | ISHARES TRcall | $11,022,826 | – | 405,400 | +100.0% | 0.43% | – |
| FXI | New | ISHARES TRchina lg-cap etf | $10,841,197 | – | 398,720 | +100.0% | 0.42% | – |
| Sell | PROCEPT BIOROBOTICS CORP | $10,447,480 | +15.0% | 295,544 | -7.6% | 0.41% | +1.2% | |
| PRAX | Buy | PRAXIS PRECISION MEDICINES I | $10,225,526 | +480.7% | 8,891,762 | +308.5% | 0.40% | +409.0% |
| Sell | ARCELLX INC | $8,089,408 | -50.1% | 255,832 | -51.3% | 0.31% | -56.1% | |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $7,730,449 | +18.3% | 8,357,242 | +39.5% | 0.30% | +4.2% |
| VEEV | New | VEEVA SYS INC | $7,399,254 | – | 37,421 | +100.0% | 0.29% | – |
| IMVT | Sell | IMMUNOVANT INC | $7,377,774 | +2.9% | 388,918 | -15.9% | 0.29% | -9.8% |
| HOWL | Buy | WEREWOLF THERAPEUTICS INC | $7,026,868 | +21.9% | 2,303,891 | +3.9% | 0.27% | +7.1% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $6,973,801 | – | 293,140 | +100.0% | 0.27% | – |
| ZLAB | New | ZAI LAB LTDadr | $6,841,157 | – | 246,706 | +100.0% | 0.27% | – |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $6,661,987 | +667.5% | 946,305 | +566.2% | 0.26% | +581.6% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $4,744,201 | – | 238,762 | +100.0% | 0.18% | – |
| New | ROIVANT SCIENCES LTD | $3,880,709 | – | 384,991 | +100.0% | 0.15% | – | |
| XENE | XENON PHARMACEUTICALS INC | $3,855,660 | +7.6% | 100,147 | 0.0% | 0.15% | -5.1% | |
| EDIT | Sell | EDITAS MEDICINE INC | $3,630,829 | -51.9% | 441,170 | -57.6% | 0.14% | -57.7% |
| VERV | VERVE THERAPEUTICS INC | $3,489,131 | +30.0% | 186,087 | 0.0% | 0.14% | +13.4% | |
| INBX | Buy | INHIBRX INC | $3,315,170 | +44.7% | 127,703 | +5.2% | 0.13% | +27.7% |
| CELC | Sell | CELCUITY INC | $2,829,689 | -11.2% | 257,713 | -17.1% | 0.11% | -22.0% |
| OSCR | New | OSCAR HEALTH INCcl a | $2,709,498 | – | 336,166 | +100.0% | 0.10% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INCcall | $2,086,400 | – | 20,000 | +100.0% | 0.08% | – |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $1,451,327 | -40.6% | 175,281 | -28.8% | 0.06% | -48.1% |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $1,429,847 | -28.3% | 228,410 | -45.4% | 0.06% | -36.4% |
| Buy | IO BIOTECH INC | $1,197,854 | +25.8% | 612,713 | +20.7% | 0.05% | +11.9% | |
| KROS | KEROS THERAPEUTICS INC | $817,663 | -5.9% | 20,350 | 0.0% | 0.03% | -15.8% | |
| QURE | Sell | UNIQURE NV | $694,671 | -98.4% | 60,617 | -97.1% | 0.03% | -98.6% |
| SANA | SANA BIOTECHNOLOGY INC | $83,237 | +82.3% | 13,966 | 0.0% | 0.00% | +50.0% | |
| VECT | Exit | VECTIVBIO HLDG AG | $0 | – | -131,922 | -100.0% | -0.05% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -439,813 | -100.0% | -0.14% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -324,982 | -100.0% | -0.26% | – |
| THC | Exit | TENET HEALTHCARE CORPcall | $0 | – | -110,600 | -100.0% | -0.29% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -318,948 | -100.0% | -0.52% | – |
| LLY | Exit | LILLY ELI & COcall | $0 | – | -39,700 | -100.0% | -0.60% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -2,162,411 | -100.0% | -0.80% | – |
| ICUI | Exit | ICU MED INC | $0 | – | -122,703 | -100.0% | -0.89% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -202,115 | -100.0% | -0.96% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -1,351,326 | -100.0% | -1.26% | – |
| UNH | Exit | UNITEDHEALTH GROUP INCput | $0 | – | -64,700 | -100.0% | -1.35% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -1,465,483 | -100.0% | -1.58% | – |
| HUM | Exit | HUMANA INCput | $0 | – | -87,900 | -100.0% | -1.88% | – |
| Exit | OAK STR HEALTH INCnote 3/1 | $0 | – | -58,500,000 | -100.0% | -2.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 44 | Q2 2024 | 2.2% |
| HCA HOLDINGS INC | 41 | Q2 2024 | 5.2% |
| HUMANA INC | 40 | Q2 2024 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 39 | Q2 2024 | 3.4% |
| UNITEDHEALTH GROUP INC | 36 | Q2 2024 | 4.8% |
| PENUMBRA INC | 36 | Q2 2024 | 4.8% |
| TENET HEALTHCARE CORP | 30 | Q2 2024 | 3.9% |
| ELEVANCE HEALTH INC | 29 | Q2 2024 | 4.2% |
| ICON PLC | 29 | Q2 2024 | 2.5% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| bluebird bio, Inc. | February 14, 2024 | ? | ? |
| Caribou Biosciences, Inc. | February 14, 2024 | ? | ? |
| ESSA Pharma Inc. | February 14, 2024 | ? | ? |
| Praxis Precision Medicines, Inc. | February 14, 2024 | ? | ? |
| Werewolf Therapeutics, Inc. | February 14, 2024 | ? | ? |
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.